Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Biotech Manufacturers to Develop Better Nucleic Acid Sample Preparation Protocols

By LabMedica International staff writers
Posted on 02 Nov 2014
Manufacturers of biotech equipment and reagents are cooperating to ease and simplify protocols for preparing samples to be analyzed by advanced next generation sequencing platforms.

The success of techniques such as next-generation sequencing, microarrays, and library construction is contingent upon the precise and accurate processing of DNA and RNA. More...
Library preparation of nucleic acids relies on a coordinated series of standard molecular biology reactions, and preparation of high quality libraries at high yield is a critical first step in the next generation sequencing workflow. The necessity for improved reagents and protocols for library preparation is growing in parallel with the increase in the number of applications for next generation sequencing.

To develop these new protocols, the instrument manufacturer Beckman Coulter Life Sciences (Nyon, Switzerland) will be collaborating with the reagent manufacturer New England Biolabs, Inc. (Ipswich, MA, USA). Beckman Coulter produces advanced automated liquid handling systems such as the Biomek 4000. New England Biolabs manufactures a line of highly pure "NEBNext" reagents that facilitate library preparation of DNA or RNA for downstream applications such as next generation sequencing and expression library construction.

It is planned that Beckman Coulter will use its extensive experience in automated next generation sequencing sample preparation to develop, distribute, and support automation for New England Biolabs' NEBNext sample preparation reagent kits. New England Biolabs will provide technical expertise on the reagents, chemistry, and protocols.

“Beckman Coulter’s focus on providing our next generation sequencing customers a top-notch portfolio of automated sample preparation solutions makes a partnership with New England Biolabs, a world leading provider of quality reagent systems for molecular biology research, a natural fit,” said Alisa Jackson, senior marketing manager, automated genomics solutions at Beckman Coulter. “Our joint collaborations with scientific researchers have already led to the development of high-quality methods demonstrated to improve efficiency, throughput and results for some of the most challenging sample inputs.”

Related Links:

Beckman Coulter Life Sciences
New England Biolabs, Inc.



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.